ARCHIVES

In Brief: O’Conor Now Top Prospect If Rauscher Leaves; Flood Gives NCI Increase Of Only $11 Million

This article is from The Cancer Letter archive.

Vol. 02 No. 20 | May 14, 1976

Download PDF Visit The Full Archive

Related Articles

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012

DCT Board Agrees To Use Of Program Announcement For New Surgery Grants

March 13, 1981

In Brief: Pelayo Correa Heads LSU Cancer Center; Foundation to Honor Feinstein, Mack

September 5, 1997

Senate Bill Gives NIH $23.7 Billion, NCI $4.25 Billion, Better Than House.

November 2, 2001

Younger Patients, More Advanced Stages, More Likely To Die From Breast Cancer

September 24, 2004